Abstract

Abstract Deletions encompassing the 1p36 region of human chromosome 1 have been associated with a spectrum of malignancies, however the tumor suppressor had not been identified. In an effort to identify tumor suppressors within this interval, we used chromosome engineering to generate mouse models with loss- and gain of regions of the genome corresponding to human 1p36. This strategy allowed us to identify a 4.3 megabase interval with potent tumor suppressive activity. Whereas loss of this region caused a marked increase in cellular proliferation that culminated in cancer in vivo, gain of the same interval triggered excessive tumor suppression as observed by augmented cellular senescence in cultured cells and apoptosis in vivo. Using genetic and molecular analyses, we identified the chromatin remodeling protein Chromodomain, helicase, DNA-binding domain protein 5 (Chd5) as the tumor suppressor within the interval, and revealed that Chd5 functions as a master regulator that facilitates p16/Rb- and p19/p53-modulated pathways. Analyses of human gliomas revealed that CHD5 is frequently deleted, suggesting that CHD5 loss contributes to malignancy. Here I will present our current efforts aimed at elucidating the epigenetic role of CHD5 in tumor suppression. Citation Information: Cancer Res 2009;69(23 Suppl):IA-1.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.